These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 510739)

  • 1. Glucagon antiserum: a tool to investigate the role of circulating glucagon in obese-hyperglycaemic (ob/ob) mice [proceedings].
    Flatt PR; Swanston-Flatt SK; Bailey CJ
    Biochem Soc Trans; 1979 Oct; 7(5):911-3. PubMed ID: 510739
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating immunoreactive glucagon concentrations in aging obese-hyperglycaemic (ob/ob) mice [proceedings].
    Flatt PR; Bailey CJ; Buchanan KD
    Biochem Soc Trans; 1980 Feb; 8(1):57-8. PubMed ID: 6989671
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon and insulin relationships in the obese hyperglycemic mouse (ob/ob).
    Mahler RJ; Dubuc PU; Mobley PW; Ensinck JW
    Horm Metab Res; 1976 Jan; 8(1):79-80. PubMed ID: 1248793
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of plasma immunoreactive glucagon in obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ; Buchanan KD
    J Endocrinol; 1982 Nov; 95(2):215-27. PubMed ID: 6757362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive glucagon levels in obese-hyperglycemic (ob/ob) mice.
    Dubuc PU; Mobley PW; Mahler RJ; Ensinck JW
    Diabetes; 1977 Sep; 26(9):841-6. PubMed ID: 892237
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucagon and diabetes: evidence for marked insensitivity to local regulation of A-cell function by endogenous insulin in obese-hyperglycaemic (ob/ob) mice [proceedings].
    Flatt PR; Buchanan KD; Bailey CJ
    Biochem Soc Trans; 1980 Feb; 8(1):58-9. PubMed ID: 6989672
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagon-like peptide-1 and the entero-insular axis in obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Life Sci; 1987 Feb; 40(6):521-5. PubMed ID: 3543585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose tolerance in aging obese (ob/ob) and lean mice.
    Dubuc PU; Ristimaki S; Cahn PJ; Willis PL
    Horm Metab Res; 1983 Mar; 15(3):120-3. PubMed ID: 6343213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
    Stevenson RW; Hutson NJ; Krupp MN; Volkmann RA; Holland GF; Eggler JF; Clark DA; McPherson RK; Hall KL; Danbury BH
    Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice.
    Fukudo S; Virnelli S; Kuhn CM; Cochrane C; Feinglos MN; Surwit RS
    Diabetes; 1989 Nov; 38(11):1433-8. PubMed ID: 2576006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin releasing effects of adrenocorticotropin (ACTH 1-39) and ACTH fragments (1-24 and 18-39) in lean and genetically obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Int J Obes; 1987; 11(2):175-81. PubMed ID: 3038765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
    Green BD; Irwin N; Gault VA; Bailey CJ; O'Harte FP; Flatt PR
    J Endocrinol; 2005 May; 185(2):307-17. PubMed ID: 15845923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice.
    Bailey CJ; Flatt PR; Atkins TW
    Int J Obes; 1982; 6(1):11-21. PubMed ID: 7040265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response.
    Hermida OG; Fontela T; Ghiglione M; Uttenthal LO
    Br J Pharmacol; 1994 Mar; 111(3):861-5. PubMed ID: 8019763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma glucose and insulin response to glucagon and arginine in Aston ob/ob mice: evidence for a selective defect in glucose-mediated insulin release.
    Flatt PR; Bailey CJ
    Horm Metab Res; 1982 Mar; 14(3):127-30. PubMed ID: 7040198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-essential role of dietary factors in the development of diabetes in ob/ob mice.
    Dubuc PU
    J Nutr; 1981 Oct; 111(10):1742-8. PubMed ID: 7026742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood glucose, plasma insulin and plasma glucagon in NZO mice.
    Upton JD; Sneyd JG; Livesey J
    Horm Metab Res; 1980 Apr; 12(4):173-4. PubMed ID: 6993323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.